The Northwestern University Robert H. Lurie Cancer Center is an NCl- designated clinical cancer center which conducts a broad range of multidisciplinary clinical and laboratory research. The Cancer Center integrates the expertise and resources of the Medical School and its five affiliated hospitals along with those of departments located on the University's Evanston campus. Established in 1974, the Lurie Cancer Center functions as a full organizational unit with the status of a department of the Medical School. The Center's specific authorities and responsibilities are reflected in the goals that were defined when the Center was established and have been maintained since that time: l. To coordinate and integrate the cancer and cancer-related activities of the University. 2. To conduct and support cancer research and to integrate cancer-related research throughout the University. 3. To develop and conduct cancer education programs. 4. To participate in the care of cancer patients at the affiliated hospitals of the McGaw Medical Center of NU. 5. To develop and implement initiatives in cancer prevention and control research. These goals are accomplished through the activities of 6 established programs and 11 shared resources. PROGRAMS 1. Molecular Oncogenesis 2. Adhesion, Motility, and Angiogenesis 3. Hormone Action and Signal Transduction 4. Differentiation and Development 5. Clinical Investigations 6. Cancer Prevention and Control Research SHARED RESOURCES 1. Media Prep Facility 2. Flow Cytometry 3. Transgenic Facility 4. 2-D Gel Facility 5. Research Histology 6. DNA-Protein Comp Facility 7. Biotechnology Facility 8. Cell Imaging Facility 9. Monoclonal Antibody Facility 10. Biometry 11. Clinical Research Office

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA060553-07
Application #
2895043
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Ptak, Krzysztof
Project Start
1993-08-01
Project End
2001-07-31
Budget Start
1999-08-16
Budget End
2000-07-31
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Mandelin 2nd, Arthur M; Homan, Philip J; Shaffer, Alexander M et al. (2018) Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis. Arthritis Rheumatol 70:841-854
Fong, Lam-Kiu; Wang, Ziwei; Schatz, George C et al. (2018) The Role of Structural Enthalpy in Spherical Nucleic Acid Hybridization. J Am Chem Soc 140:6226-6230
Suraneni, Praveen K; Corey, Seth J; Hession, Michael J et al. (2018) Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity. Blood Adv 2:3540-3552
Yan, M; Lewis, P L; Shah, R N (2018) Tailoring nanostructure and bioactivity of 3D-printable hydrogels with self-assemble peptides amphiphile (PA) for promoting bile duct formation. Biofabrication 10:035010
Edelbrock, Alexandra N; Àlvarez, Zaida; Simkin, Dina et al. (2018) Supramolecular Nanostructure Activates TrkB Receptor Signaling of Neuronal Cells by Mimicking Brain-Derived Neurotrophic Factor. Nano Lett 18:6237-6247
Fisher, Daniel W; Han, Ye; Lyman, Kyle A et al. (2018) HCN channels in the hippocampus regulate active coping behavior. J Neurochem 146:753-766
Sullivan, David P; Bui, Triet; Muller, William A et al. (2018) In vivo imaging reveals unique neutrophil transendothelial migration patterns in inflamed intestines. Mucosal Immunol 11:1571-1581
Russi, Abigail E; Ebel, Mark E; Yang, Yuchen et al. (2018) Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc Natl Acad Sci U S A 115:E1520-E1529
Frankowski, Kevin J; Wang, Chen; Patnaik, Samarjit et al. (2018) Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Sci Transl Med 10:
Melo-Cardenas, Johanna; Xu, Yuanming; Wei, Juncheng et al. (2018) USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism. Blood 132:423-434

Showing the most recent 10 out of 1972 publications